Global Head And Neck Cancer (HNC) Market Trends and Future Outlook to 2029
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What CAGR And Valuation Are Anticipated For The Head And Neck Cancer (HNC) Market?
The market size for head and neck cancer (hnc) has seen considerable growth in the past few years. Forecasted to expand from $2 billion in 2024 to $2.16 billion in 2025, it’s expected to maintain a compound annual growth rate (CAGR) of 8.2%. Factors contributing to this growth during the historic period include a rise in HPV-related cancers, greater prevalence of smoking and alcohol consumption, increased investment in cancer research, heightened awareness and early detection, and an aging demographic.
The market for head and neck cancer (hnc) is set for robust growth in the upcoming years, with it expanding to $2.91 billion in 2029, representing a compound annual growth rate (CAGR) of 7.7%. The anticipated growth over the forecast period is due to factors such as enhanced healthcare infrastructure, growing patient demographics, an increasing elderly population, escalating healthcare expenses, and widespread tobacco usage and alcohol consumption. Key emerging trends over the forecast span include advances in immunotherapy, targeted treatments, incorporation of technology, application of artificial intelligence (AI), and accuracy in medical treatment.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20825&type=smp
What Are The Primary Factors Supporting The Head And Neck Cancer (HNC) Market Expansion?
The rise in cigarette smoking occurrences is anticipated to boost the head and neck cancer (HNC) market’s expansion. Cigarette smoking entails breathing in and out smoke from cigarettes filled with burning tobacco and is frequently linked to health hazards and dependency. Factors like tension, societal influences, assertive advertising, and the easy availability of tobacco items often escalate cigarette smoking incidences. Drugs for head and neck cancer work to counteract the adverse impacts of cigarette smoking by targeting changes at the molecular level induced by smoking and dealing with cancers linked to tobacco consumption, as well as underlining the importance of decreasing exposure to carcinogens associated with smoking for improved treatment outcomes. For example, a study conducted by the European Respiratory Society (ERS), a non-profit organization based in Switzerland, covering smoking habits among youth indicated a notable upsurge in smoking rates. In comparison to 22.5% of respondents who smoked in 2022, the percentage rose to 40.1% in 2024. Thus, the surge in cigarette smoking prevalence contributes to the head and neck cancer (HNC) market’s growth.
Which Segments Define The Structure Of The Head And Neck Cancer (HNC) Market?
The head and neck cancer (hnc)market covered in this report is segmented –
1) By Type: Laryngeal Cancer, Pharyngeal Cancer, Salivary Gland Cancer, Lip And Oral Cavity Cancer, Nasopharyngeal Cancer, Other Types
2) By Treatment: Chemotherapy, Surgery, Radiation Therapy, Targeted Therapy, Other Treatments
3) By Diagnosis: Bioscopy Screening Tests, Blood Tests, Dental Diagnosis, Imaging, Endoscopy
4) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, E-commerce
5) By End User: Hospital, Specialty Clinics, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Laryngeal Cancer: Supraglottic Laryngeal Cancer; Glottic Laryngeal Cancer; Subglottic Laryngeal Cancer
2) By Pharyngeal Cancer: Oropharyngeal Cancer; Nasopharyngeal Cancer; Hypopharyngeal Cancer
3) By Salivary Gland Cancer: Parotid Gland Cancer; Sublingual Gland Cancer; Submandibular Gland Cancer; Minor Salivary Gland Cancer
4) By Lip And Oral Cavity Cancer: Lip Cancer; Buccal Mucosa Cancer; Tongue Cancer; Gingival Cancer; Palate Cancer
5) By Nasopharyngeal Cancer: Early-Stage Nasopharyngeal Cancer; Advanced-Stage Nasopharyngeal Cancer
6) By Other Types: Thyroid Cancer; Esophageal Cancer; Sinonasal Cancer
What Strategic Shifts And Innovations Are Influencing The Head And Neck Cancer (HNC) Market?
Several leading corporations in the Head and Neck Cancer (HNC) market are directing their focus towards the development of innovative formulations such as immune oncology drugs. These initiatives aim to boost the effectiveness of treatment, increase patient survival chances, and address the gaps in medical treatment for complicated and late-stage cancers. Immuno-oncology treatments refer to those that utilize the body’s immunity to identify and combat cancer cells. These treatments encompass checkpoint inhibitors, CAR-T cell therapies, and cancer vaccines. For example, in November 2024, Dr. Reddy’s Laboratories, a pharmaceutical firm based in India, brought toripalimab, an immune oncology drug for adults, to market. This drug is used to treat a rare type of head and neck cancer that starts in the nasopharynx, the upper section of the throat, specifically recurrent or metastatic nasopharyngeal carcinoma. It will be traded under the brand name Zytorvi. When used along with the standard chemotherapy (gemcitabine and cisplatin), the drug has shown a 48% decrease in the chance of progression or death.
Who Are The Primary Market Leaders In The Head And Neck Cancer (HNC) Market?
Major companies operating in the head and neck cancer (HNC) market are Pfizer Inc., Siemens Healthcare Private Limited, F. Hoffmann-La Roche Ltd., Merck KGaA, AbbVie Inc., Bayer Healthcare AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca Plc, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Koninklijke Philips N.V., Boehringer Ingelheim, Fresenius Kabi AG, Incyte Corporation, Exelixis Inc., Astellas Pharma Inc., Rakuten Medical Inc., Merus N.V.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/head-and-neck-cancer-hnc-global-market-report
What Regional Factors Are Accelerating Growth In The Head And Neck Cancer (HNC) Market?
North America was the largest region in the head and neck cancer (HNC) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the head and neck cancer (HNC) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=20825&type=smp
Browse Through More Reports Similar to the Global Head And Neck Cancer (HNC) Market 2025, By The Business Research Company
Hepatocellular Carcinoma Drugs Global Market Report 2025
Unresectable Hepatocellular Carcinoma Global Market Report 2025
Merkel Cell Carcinoma Treatment Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
